MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/prs.0000000000011485

Медицинская библиотека · Plastic and reconstructive surgery · 2024

A Ropivacaine-Eluting Poly(Lactide-Co-Caprolactone) Wound Dressing Provided Enhanced Analgesia in Partial-Thickness Porcine Injuries.

Niederauer Stefan, Beeman Mike, Cleveland Andrew, Wojtalewicz Susan, Erickson Sierra, Reilly Christopher A, Rower Joseph E, Garrett Caroline, Floyd Candace, Shea Jill, Agarwal Jay, Lade Caleb, Davis Brett

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Partial-thickness skin wounds are some of the most painful injuries because of large areas of exposed nerve endings. These injuries often require systemic opioid treatment to manage pain adequately. However, the Centers for Disease Control and Prevention reported nearly 17,000 prescription opioid-related deaths in the United States in 2021 alone, highlighting the ongoing need for nonopioid treatment strategies. The authors developed a novel single-application ropivacaine-eluting primary wound dressing that could provide sustained ropivacaine delivery to partial-thickness wounds and assessed its in vivo feasibility for prolonged nonopioid analgesia.

METHODS

Sustained release of ropivacaine from a poly(lactide-co-caprolactone) matrix was first optimized in vitro using dissolution testing and a Box Behnken design of experiments. The optimized dressing was then tested against a clinical control silicone dressing in a porcine partial-thickness wound study to assess analgesic effect, pharmacokinetics, and wound healing.

RESULTS

The ropivacaine-eluting dressing showed a moderate analgesic effect in vivo, where normalized single pinprick scores significantly improved pain over the testing period (4 to 168 hours) (control versus treatment: 232 ± 25% versus 145 ± 16%; P < 0.0003). Ropivacaine blood plasma levels peaked at 8 hours after treatment, with a maximum concentration of 246 ± 74 ng/mL. No significant differences in wound healing were found when compared with control.

CONCLUSION

The ropivacaine-loaded poly(lactide-co-caprolactone)-based wound dressing provided sustained delivery of ropivacaine to partial-thickness skin wounds and enhanced analgesic effect compared with a clinical standard control dressing.

CLINICAL RELEVANCE STATEMENT: This article describes the development and porcine testing of an analgesic wound dressing for management of acute pain in partial-thickness dermal wounds.

Для цитирования: Niederauer Stefan, Beeman Mike, Cleveland Andrew, Wojtalewicz Susan, Erickson Sierra, Reilly Christopher A, Rower Joseph E, Garrett Caroline, Floyd Candace, Shea Jill, Agarwal Jay, Lade Caleb, Davis Brett. A Ropivacaine-Eluting Poly(Lactide-Co-Caprolactone) Wound Dressing Provided Enhanced Analgesia in Partial-Thickness Porcine Injuries.. Plastic and reconstructive surgery. 2024. DOI: 10.1097/prs.0000000000011485.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.